The Neuroendocrine Tumor Research Foundation (NETRF) is the leading private funder of research into causes and treatments of neuroendocrine tumors (NETs) to improve and extend the lives of those living with NETs.
Increasing Precision in Cancer Cell Death to Prevent Metastasis In housework and lawn work, it is important to have the right tool for the job.
Mark A. Lewis, MD, Director of Gastrointestinal Oncology, Intermountain Healthcare, Utah, has joined the Board of Directors for the Neuroendocrine Tumor Research Foundation. Dr. Lewis,
NETRF given the highest ranking for financial responsibility and transparency by leading nonprofit rating program, GoldStar.
NETRF is so pleased to report that we received several gifts honoring many NET doctors around the country on March 30th, National Doctor’s Day! Thank
The Neuroendocrine Tumor Research Foundation (NETRF) announces a new NETRF Mentored Award for early career researchers, supported by Ipsen. The two-year grant for those in
A few weeks ago, I heard Dr. James Allison, a scientist at MD Anderson Cancer Center and winner of the 2018 Nobel Prize for Physiology
NETRF invites your participation in a special, upcoming holiday. National Doctor’s Day will be celebrated on Saturday, March 30th and it is a great opportunity
by Susan Payson NETRF Chief Development Officer Here in the NETRF office in Boston, we have a large brass bell. Our practice is to ring
High School Student Finds Creative Way to Raise Money for NET Research Lilly is midway through twelth grade. Being a senior is typically the highlight
Dr. Sonia Lupien, Director of the Centre for Studies on Human Stress at the University of Montreal, delivered an informative and uplifting talk on the